| Literature DB >> 19471282 |
Meinrad Gawaz, Tobias Geisler.
Abstract
Dual antiplatelet therapy with aspirin and clopidogrel is effective in limiting adverse coronary thromboischemic events in most patients undergoing coronary stenting. However, platelet reactivity to clopidogrel is variable and stent thrombosis can occur suddenly and unexpectedly in up to 3% of patients. Is responsiveness to clopidogrel an indicator of risk of post-treatment thromboischemic events?Entities:
Mesh：
Substances：
Year: 2009 PMID： 19471282 DOI： 10.1038/nrcardio.2009.76
Source DB: PubMed Journal: Nat Rev Cardiol ISSN： 1759-5002 Impact factor: 32.419